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Available online 19 November 2015Polychlorinated biphenyls (PCBs) induce the expression of the proto-oncogene c-mycwhich has a role in cellular
growth and proliferation programs. The c-myc up-regulates the telomerase reverse transcriptase which adds the
telomeres repeating sequences to the chromosomal ends to compensate for the progressive loss of telomeric se-
quence. We performed multivariate linear regression to analyze the association of PCBs, polychlorinated
dibenzo-p-dioxins, and 1,2,3,4,6,7,8-heptachlorodibenzofuran with leukocyte telomere length (LTL) in the
adult population (n= 2413) of the National Health and Nutrition Examination Survey 1999–2002. LTL was nat-
ural log-transformed and the results were re-transformed and presented as percent differences. Individuals in
the 3rd and 4th quartiles of the sum of PCBs were associated with 8.33% (95% CI: 4.08–13.88) and 11.63% (95%
CI: 6.18–17.35) longer LTLs, respectively, compared with the lowest quartile, with evidence of a dose–response
relationship (p-trend b 0.01). The association of the sum PCBs with longer LTL was found in both sexes.
Additionally, 1,2,3,4,6,7,8-heptachlorodibenzofuran and 1,2,3,6,7,8-hexachlorodibenzo-p-dioxinwere associated
with longer LTL. The age independent association between longer LTL and environmental exposures to PCBs,
1,2,3,4,6,7,8-heptachlorodibenzofuran and 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin may support a role as
tumor promoter of these compounds. Further studies to evaluate the effect of these compounds on LTL are need-
ed to more fully understand the implications of our finding.
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NHANES1. Introduction
Persistent organic pollutants (POPs) are lipophilic stable chemicals
that bio-accumulate in adipose tissue of living organism (Van den Berg
et al., 1998). Most POPs, such as polychlorinated biphenyls (PCBs),
have already been banned in many countries. However, because of
their persistence, along with the fact that production and release into
the global environment is still occurring in some countries they are still
present in the environment and food supply (Lauby-Secretan et al.,
2013). Therefore, they are continually posing health hazards. POPs such
as PCBs, polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated di-
benzofurans (PCDFs) are associated with increased risks for various
chronic diseases and cancer (ATSDR, 2000, 2002a, 2002b). There are
209 possible PCB congeners with different numbers and positions of
substituted chlorine atoms on the aromatic rings. PCBs can act as
endocrine-disrupting agents and both estrogenic and anti-estrogenic ef-
fects of PCBs have been reported in various in vitro and in vivomodels.
Non-planar PCBs have been reported to have weak estrogenic activity
(Faroon et al., 2001), whereas, anti-estrogenic activity has beenndPrevention, Agency for Toxic
7, Atlanta, GA 30341, USA.
ss article under the CC BY-NC-ND licfrequently reported in coplanar dioxin-like PCBs through aryl hydrocar-
bon receptor (AhR)-dependent mechanisms (Safe and Wormke, 2003;
Oenga et al., 2004). The degree to which a particular coplanar dioxin-
like PCBs congener act on the AhR is measured in Toxic Equivalents
(TEQs), a comparison with a standard set to the highly toxic dioxin-like
compound 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) (Van den Berg
et al., 1998; Van den Berg et al., 2006).
In vitro studies show that PCBs induce the expression of c-mycwhich
has a role in cellular growth and proliferation programs (Dang, 2013).
The proto-oncogene c-myc up-regulates the telomerase reverse tran-
scriptase (TERT), which add the telomeres repeating hexanucleotide
(TTAGGG) sequences to the chromosomal ends to compensate for the
progressive loss of telomeric sequence, thus promoting chromosomal
stability (Aubert and Lansdorp, 2008). With each cell replication, telo-
meres shorten and ultimately lead to apoptosis or permanent cell-
cycle arrest. Absolute telomere length (TL) depends on an individual's
age, cellular replicative history, and tissue type (Aubert and Lansdorp,
2008). Several studies have found that, independently of chronological
age, shorter telomere length is associated with cardiovascular diseases
(Haycock et al., 2014), diabetes (Zee et al., 2010), and mortality
(Weischer et al., 2012). Germ cells, certain white blood cells, and cancer
cells have active telomerase enzyme, which make them relatively long-
lived compared to other cell types (Aubert and Lansdorp, 2008). Longerense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of accumulation of genetic mutations; therefore, longer TL could be as-
sociated with the possibility of accumulating cancer-promoting muta-
tions (Noy, 2009). On the other hand, excessive telomere loss may
lead to genomic instability and promote carcinogenesis (Blasco, 2005).
Until now, the epidemiological evidence for associations between LTL
and cancer has been inconsistent with results reporting positive, nega-
tive, or null associations and this inconsistency may, among others, be
attributed to technical methodology (Cunningham et al., 2013), and to
the fact that specific cancer types may have different effects on LTL
(Gu and Wu, 2013). Shorter telomeres are associated with increased
risk for several cancers, among them bladder, breast, ovaries, kidneys,
head and neck, esophagus, stomach, and lung cancer (Wentzensen
et al., 2011). However, the meta-analyses stratified by study designed
conducted by Wentzensen et al. (Wentzensen et al., 2011) reported
that the increased cancer risk with short telomeres was mainly driven
by case–control studies, thus, suggestive of a possible effects of reverse
causation in case–control studies where the cancer itself or the thera-
peutic procedures may affect telomere length. In prospective studies,
long telomeres have been associated with an increased risk of several
cancers such as melanoma (Han et al., 2009), lung cancer (Lan et al.,
2013; Seow et al., 2014), non-Hodgkin lymphoma (Lan et al., 2009),
pancreatic cancer (Lynch et al., 2013), and prostate cancer (Julin et al.,
2015). Interestingly, in a 12 years follow-up of 792 Normative Aging
Study participants, Hou and colleagues (Hou et al., 2015) reported
age-related LTL attrition among those who developed prostate and
other cancers. However, they observed a decelerating age-adjusted
LTL attrition in cancer cases as they approached diagnosis with signifi-
cant longer LTL within 4 years pre-diagnosis. The findings lead the au-
thors to suggest that “telomere-elongating mechanisms in blood
leukocytes may also be activated by cancer initiation, leading to LTL
elongation early during cancer development.” (Hou et al., 2015) Recent-
ly, in a small cross-sectional study conducted in 84 healthy Korean
adult, low-dose exposure to POPs, including PCBs were associated
with longer leukocyte telomere length (LTL) (Shin et al., 2010). In this
study we investigated the potential association on blood level of POPs
(PCBs, PCDDs, and PCDFs) with LTL in a nationally representative sam-
ple of the non-institutionalized civilian US adult population (20 years
and older) who participated in theNational Health and Nutrition Exam-
ination Survey (NHANES) from 1999 to 2002.
2. Methods
2.1. Study Design and Population
NHANES is a cross-sectional, nationally representative survey of the
non-institutionalized civilian population of the United States conducted
annually by the National Center for Health Statistics (NCHS), Centers for
Disease Control and Prevention (CDC) (Johnson et al., 2013). NHANES
uses a complex, multistage probability sampling design, with
oversampling of certain subgroups. Participants complete household
surveys that include questions about demographics and health history,
and they provide blood and urine samples collected during the physical
examinations at mobile exam centers. All procedures are approved by
the NCHS Research Ethics Review Board (Protocol #98-12 http://
www.cdc.gov/nchs/nhanes/irba98.htm), and all participants provide
written informed consent. The grouping we used consisted of 2 cycles
(1999–2000 and 2001–2002) that were combined using NCHS recom-
mendations (Johnson et al., 2013).
2.2. Measurements of POPs in Serum
PCBs, PCDDs, and PCDFs were measured for a randomly selected
subsample that included one-third of NHANES participants. The individ-
ual chemicals were measured by high-resolution gas chromatography/
isotope-dilution high-resolution mass spectrometry (HRGS/ID-HRMS).NHANES provides congener concentrations both on a weight–weight
basis and lipid adjusted using concentrations of serum total cholesterol
and triglycerides; we used the latter in our analyses. Although 49 POPs
were measured in both NHANES 1999–2000 and 2001–2002, to avoid
bias in estimation among those below the limit of detection (LOD), we
selected the 11 POPs for which at least more than 72% of study subjects
had concentrations NLOD: 3 PCDDs [1,2,3,6,7,8-hxcdd (bLOD=27.5%);
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin (bLOD = 13.8%); and
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin (bLOD = 20.3%)], 1 PCDFs
[1,2,3,4,6,7,8-Heptachlorodibenzofuran ((bLOD = 27.8%)], 2 dioxin-
like PCBs [PCB126 (bLOD = 24.0%) and PCB169 (bLOD = 22.9%)], 3
non-dioxin-like PCBs [PCB138 (bLOD = 25.6%), PCB153 (bLOD =
20.8%), and PCB180 (bLOD = 22.5%)].
Three PCB exposure metrics were calculated to reflect the
biomechanism related to dioxins: (Faroon et al., 2001) a) the sum of all
5 PCB congeners (∑PCBs); b) the sum of 3 non-dioxin-like PCBs (conge-
ners 138, 153, and 180); and c)the sum of 2 dioxin-like PCBs (congeners
126, and 169). In a complementary analysis, we applied toxic equivalency
factors (TEFs) published by theWorld Health Organization in 2005 to ac-
count for the relative toxicity and concentration of dioxin-like congeners
(Van den Berg et al., 2006), and we summed the values to obtain the
toxic equivalents (TEQs). Therefore, we will have: i) a toxic equivalent
dioxin-like (TEQDL) representing the sum of the TEFs of the 3 PCDDs,
the 1,2,3,4,6,7,8-heptachlorodibenzofuran, and PCB126 and PCB169; and
ii) a toxic equivalent dioxin-like PCBs that is the TEF sum of PCB126 and
PCB129. For compounds measures at or below the detection limit, the
valueswere recorded as the detection limit divided by the square root of 2.
2.3. LTL Measurements
Briefly, aliquots of purified DNA, isolated from whole blood using the
Puregene (D-50 K) kit protocol (Gentra Systems, Inc., Minneapolis, Min-
nesota), were provided byNCHS. The LTL assaywas performed in the lab-
oratory of Dr. Elizabeth Blackburn at the University of California, San
Francisco, using the quantitative polymerase chain reaction method to
measure LTL relative to standard reference DNA (also known as the T/S
ratio) (Needham et al., 2013). Each sample was assayed 3 times on 3 dif-
ferent days. The samples were assayed on duplicate wells, resulting in 6
data points. Control DNA values were used to normalize between-run
variability. Runs with more than 4 control DNA values falling outside 2.5
standard deviations from the mean for all assay runs were excluded
from further analysis (b6% of runs). For each sample, any potential out-
lierswere identified and excluded from the calculations (b2%of samples).
The CDC conducted a quality control review before linking the LTL data to
the NHANES public-use data files. The CDC Institutional Review Board
provided human subject approval for this study. LTL was not normally
distributed, thus it was natural log-transformed in our analyses.
2.4. Covariates
Modelswere adjusted for a priori factors based on previous literature
demonstrating an association with LTL (Needham et al., 2013). These
variables were age (years, continuous), age squared, sex, education
(less than high-school, high school graduate, some college and above),
race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican
American, multiracial, or other), alcohol consumption (amount con-
sumed per week, categorized as no alcohol, 1–4 drinks/week, of N4
drinks/week), self-reported smoking status (current, former, or never
smoker), serum cotinine (natural log-transformed), and body mass
index. BMI was obtained from the physical examination and was calcu-
lated by dividing measured weight in kilograms by measured height in
meters squared. Since inflammation is associated with telomere length
(Rode et al., 2014), additional adjustment for c-reactive protein (a bio-
marker for inflammation) was used as a sensitivity analysis. PCBs act
as endocrine-disrupting agents through sex hormone-related nuclear
receptors (Safe, 2000), and hormonal regulation of telomere length is
Table 1
Sample size andweighted characteristics of the NHANES 1999–2002 participants 20 years
and older.
ALL
n Weighted
2431
Sex
Men 1152 48.70 (1.11)
Women 1279 51.30 (1.11)
Age (Years), GM (SE) 2431 42.81 (0.52)
BMI(kg/m2), GM (SE) 2431 27.23 (0.17)
Serum cotinine (ng/mL), GM (SE) 2431 0.68 (0.09)
Mean telomere length, GM (SE) 2431 1.03 (0.01)
Smoking status
Current smoker, % (SE) 535 25.51 (1.18)
Former smoker, % (SE) 669 26.13 (1.35)
Never smoked, % (SE) 1227 48.37 (1.06)
Alcohol consumption
No alcohol, % (SE) 850 30.58 (1.93)
1–4 drinks per week, % (SE) 1391 61.58 (2.26)
N4 drinks per week, % (SE) 190 7.84 (0.76)
Education level
Less than high school % (SE) 821 21.77 (1.21)
Completed high school % (SE) 537 24.31 (1.61)
More than high school % (SE) 1073 53.92 (1.65)
Race/Ethnicity
White (non-Hispanic) % (SE) 1219 72.25 (2.02)
Non-Hispanic Black % (SE) 425 10.10 (1.31)
Mexican-American % (SE) 576 6.96 (1.75)
Other Hispanic and other % (SE) 211 10.70 (1.78)
Table 2
Distribution of serum compound concentrations in the adults study population (20 years
and older), NHANES 1999–2002.
n GM (SE)
∑PCBs lipid adj (ng/g) 2175 82.13 (2.55)
∑ Non-dioxin-like lipid adj (ng/g) 2413 81.89 (2.54)
PCB138 lipid adj (ng/g) 2422 23.23 (0.73)
PCB153 lipid adj (ng/g) 2422 33.95 (1.06)
PCB180 lipid adj (ng/g) 2424 23.16 (0.76)
∑Dioxin-like PCBs lipid adj (pg/g) 2202 38.31 (1.29)
PCB 126 lipid adj (pg/g) 2215 18.72 (0.69)
PCB 169 lipid adj pg/g) 2216 16.19 (0.51)
∑PCDDs lipid adj (pg/g) 2115 370.90 (14.02)
1,2,3,6,7,8-hxcdd. lipid adj (pg/g) 2215 21.45 (1.15)
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin lipid adj (pg/g) 2203 37.78 (1.57)
1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin lipid adj (pg/g) 2175 296.91 (10.90)
PCDF
1,2,3,4,6,7,8-Heptachlorodibenzofuran (pg/g) 2090 7.70 (0.29)
TEQDL lipid adj (pg/g) 1976 6.01 (0.23)
TEQPCB lipid adj (pg/g) 2202 2.53 (0.09)
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lyze the association of the sum of PCBswith LTL by gender stratification.
2.5. Statistical Analysis
All analyses were performed using the weights from the dioxin sub-
sample as recommended by NCHS to account for the complex sampling
design and non-response of NHANES and were calculated according to
NHANES guidelines (Johnson et al., 2013). SAS 9.3 (SAS Institute, Cary,
NC) was used for all statistical analyses and SAS-Callable SUDAAN 10
(Research Triangle Institute, Research Triangle Park, NC) was used to
account for the NHANES complex sample design. All tests were two
sided, and p b 0.05 was the level of significance. POPs were categorized
as weighted quartiles based on the distribution of serum POP levels
among the study population, resulting in approximately the same num-
ber of participants within each quartile. Evaluation of chemical outliers
was performed by sampling weight as described by CDC NHANES tutori-
al (http://www.cdc.gov/nchs/tutorials/nhanes/Preparing/CleanRecode/
Task3.htm). Exclusion of the POP outliers did not change the statistical
significance of the results (data not shown).Therefore all the analyses
are presented with the inclusion of the chemical outliers.
We used multivariate linear regression to calculate adjusted β-
coefficients for the associations between natural log-transformed LTL
and quartiles of POPs. Since our dependent variable, LTL, was log-
transformed, the results were re-transformed by exponentiation of the
β coefficients (eβ≈1+β) and presented as percent differences estimat-
ed by comparing each of the upper 3 quartiles to the lowest quartile;
statistical tests for linear trends were conducted by modeling quartiles
as an ordinal variable using integer values.
3. Results
The mean (standard error) LTL of the study population (n = 2431)
was 1.06 (0.02). Theweighted distributions of study population charac-
teristics of the total sample are shown in Table 1). Women represented
slightly over 51% of the total sample; the geometricmean age of the par-
ticipantswas approximately 43 years old, obesity prevalencewas slight-
ly higher of 29% and the prevalence of current smokers was 25.51%.
Table 2 show the geometric mean (GM) and standard error (SE) of the
serum POP concentrations among the participants in our study.
Table 3 shows the results of the multivariable linear regression.
Briefly, in the adjusted model, the 3rd and 4th quartiles of the sum of
PCBs (∑PCBs) were associated with 8.33% (95% CI: 4.08–13.88) and
11.63% (95% CI: 6.18–18.53) longer LTLs, respectively, compared with
the lowest quartile. There was evidence of dose–response relationship
(p-value for trend b0.01). Similarly, the sum of non-dioxin-like PCBs,
as well as the individual congeners PCB138, PCB153, PCB180 (Supple-
mental Table 1), were statistically significantly associated with longer
LTL for the highest 3rd and 4th quartiles. The highest 3rd and 4th quar-
tiles of the sum of dioxin-like PCBs compared to the lowest quartile
were also associated with longer LTL with a dose–response relationship
(Table 3). The samewas found for the congener PCB169 (Supplemental
Table 1), whereas only the highest quartile of PCB126 was associated
with longer LTL (Supplemental Table 1).
Among the other compounds investigated, the highest quartile of the
polychlorinated dibenzodioxin 1,2,3,4,6,7,8-heptachlorodibenzofuran
was associated with longer LTL compared with the lowest, quartile
(Table 3). There was a statically significant association of shorter LTL
with age. For each year unit, LTL decreased of 0.80% (95% CI:−1.09 to
−0.40) (data not shown).
No significant associationswere observed between LTL and the sumof
PCDD (Table 3), however the congener 1,2,3,6,7,8-hexachlorodibenzo-p-
dioxin)was associatedwith longer LTL (Supplemental Table 1). However,
this association was not linear as indicated but the lack of statistical asso-
ciation between natural log-transformed 1,2,3,6,7,8-hexachlorodibenzo-
p-dioxin and LTL (Supplemental Table 2). Analyses stratified by sex,confirmed the association of∑PCBs, with longer LTL in both sexes (Sup-
plemental Table 3). In complementary analyses using TEQ, the highest
quartiles of TEQDL and the TEQPCBs, compared with the respective low-
est quartiles, were associated with 11.63% (95% CI: 4.08–18.53) and 6.18
(95% CI: 1.01–11.63) longer LTL; both demonstrated a dose–response re-
lationship (Table 4).
Complementary analyses using the natural log transformed com-
pounds found a statistical significant association of the compound used
in the primary analyses, except for 1,2,3,6,7,8-hexachlorodibenzo-p-di-
oxin (Supplemental Table 2). Sensitivity analyses including c-reactive
protein measurements yielded results similar to those from the primary
analyses (data not shown).
Table 3
Percent difference (95% CI)* in leukocyte telomere length by POP exposure, NHANES
1999–2002.*
∑PCBs N = 2175
Q1 ≤ 45.70 ng/g Referent
Q2 45.71–81.00 ng/g 3.05 (−1.00, 6.18)
Q3 81.01–142.79 ng/g 8.33 (4.08–13.88)
Q4 N 142.80 ng/g 11.63 (6.18–17.35)
p trend b0.001
R-square 0.194
∑ Non-dioxin-like (PCB 138 + PCB 153 + PCB 180) N = 2413
Q1 ≤ 45.65 ng/g Referent
Q2 45.66–80.95 ng/g 3.05 (−1.00–6.18)
Q3 80.96–143.99 ng/g 8.33 (4.08–13.88)
Q4 N 143.99 ng/g 11.63 (6.18–18.53)
p trend b0.001
R-square 0.196
∑ Dioxin-like PCB (PCB 126 + PCB 169) N = 2202
Q1 ≤ 21.93 pg/g Referent
Q2 21.94–38.58 pg/g 3.05 (−1.00–6.18)
Q3 38.59–64.43 pg/g 6.18 (2.02–10.52)
Q4 N 64.43 pg/g 9.42 (3.05–16.18)
p trend 0.01
R-square 0.193
∑PCDDs N = 2115
Q1 ≤ 212.42 pg/g Referent
Q2 212.43–359.62 pg/g −1.00 (−6.76–4.08)
Q3 359.63–628.46 pg/g 2.02 (−2.96–7.25)
Q4 N 628.46 pg/g 3.05 (−3.92–10.52)
p trend 0.02
R-square 0.187
PCDF
1,2,3,4,6,7,8-Heptachlorodibenzofuran (pg/g) N = 2090
Q1 ≤ 4.62 pg/g Referent
Q2 4.63–7.88 pg/g 5.13 (1.01–9.42)
Q3 7.89–12.46 pg/g 2.02 (−1.98–6.18)
Q4 N 12.46 pg/g 7.25 (3.05–11.63)
p trend 0.01
R-square 0.195
⁎ Adjusted for age (years, continuous), age squared, education (less than high-school,
high school graduate, some college and above), race/ethnicity (non-Hispanic white, non-
Hispanic black, Mexican American, multiracial, or other), alcohol consumption, self-re-
ported smoking status (current, former, or never smoker), serum cotinine (natural log-
transformed),BMI and sex.
Table 4
Percent difference (95% CI) in leukocyte telomere length by TEQDL and
TEQ PCBs exposure, National Health and Nutrition Examination Sur-
vey, 1999–2002⁎.
TEQDL N = 1976
Q1 ≤ 3.61 Referent
Q2 3.62–6.17 4.08 (−1.00–9.42)
Q3 6.18–9.94 5.13 (−1.00–10.52)
Q4 N 9.94 11.63 (4.08–18.53)
p trend 0.01
R-square 0.206
TEQPCBs N = 2202
Q1 ≤ 1.33 Referent
Q2 1.34–2.59 −1.00 (−4.88–3.05)
Q3 2.60–4.47 4.08 (−0.50–8.33)
Q4 N 4.47 6.18 (1.01–11.63)
p trend 0.01
R-square 0.191
⁎ Adjusted for age (years, continuous), age squared, education (less
than high-school, high school graduate, some college and above), race/
ethnicity (non-Hispanic white, non-Hispanic black, Mexican American,
multiracial, or other), alcohol consumption, self-reported smoking sta-
tus (current, former, or never smoker), serum cotinine (natural log-
transformed),BMI and sex.
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In this study, we found that∑PCBs and the individual congeners as
well as the 1,2,3,4,6,7,8-heptachlorodibenzofuran and the 1,2,3,6,7,8-
hexachlorodibenzo-p-dioxin were associated with longer LTL. Our re-
sults are consistent with those reported by a study restricted to the
NHANES 2001–2002 cycle dataset. Mitro and colleagues (Mitro et al.,
2015) reported an association of dioxin-like PCBs (PCB126 and
PCB169) and toxic equivalency (TEQ) (comprised of 7 dioxins, 9 furans,
2 non-ortho-substituted PCBs, and 6 mono-ortho-substituted PCBs)
with longer LTL. The authors, also, reported an association of non-
dioxin-like PCBs (comprised of 10 non-dioxin-like PCB congeners)
with longer LTL; however, non-dioxin-like PCBs was not associated
with longer LTL after adjustment for dioxin-like PCBs (Mitro et al.,
2015). In our analyses, non-dioxin-like PCBs was still associated with
longer LTL after adjustment for natural log-transformed sum of
dioxin-like PCBs or TEQ (data not shown). The discrepancy with our
finding of an association of non-dioxin-like PCBs to longer LTL may be
due to sample size and the numbers of POP compounds used. We com-
bined two NHANES cycle, thus increasing the sample size. Also, we lim-
ited our analyses only to compounds that were measured at or above
the LOD in 75% of the sample, whereas Mitro et al. (Mitro et al., 2015)
used PCBs congeners and dioxin and furans compounds that were de-
tected at or above LOD in 50%of samples. There could, also, be difference
in independent variables entered in the models. For example, Mitro
et al. (Mitro et al., 2015) used, as independent variables, self-reported
cancer and the percentage of white cell populations. However, addingto our analyses self-reported cancer as independent variable did not
change the statistically significant association that we reported (data
not shown).
Our results on the association between PCBs and longer LTL are con-
sistent with the findings reported by Shin and colleagues (Shin et al.,
2010) in a cross-sectional study consisting of 84 healthy Korean individ-
uals (33men and 51women)with amean age of 56 years (range 42–69
years). The authors reported a positive association of several PCBs —
PCB99, PCB153, PCB180, PCB183 and PCB187 — with longer LTL (Shin
et al., 2010).
In their evaluation on polychlorinated dibenzo-para-dioxins and
polychlorinated dibenzofurans, the International Agency for Research on
Cancer (IARC) classified 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as
carcinogenic to humans (IARC group 1 classification) but other poly-
chlorinated dibenzo-p-dioxins, the nonchlorinated dibenzo-p-dioxin,
and polychlorinated dibenzofurans were evaluated as not classifiable as
to their carcinogenicity to humans (group 3) (IARC, 1997). PCBs are clas-
sified as probable carcinogens by the US Environmental Protection Agen-
cy (EPA) (USEPA, 1997). Recently, the IARC concluded that “there is
sufficient evidence in humans for the carcinogenicity of polychlorinated bi-
phenyls (PCBs). PCBs cause malignant melanoma. Positive associations
have been observed for non-Hodgkin lymphoma and cancer of the
breast.” (IARC, 2015).
Furthermore, PCB126 and PCB169 were classified by IARC as a
human carcinogen (IARC group 1 classification) (IARC, 2015).
A recent systematic review and meta-analysis found evidence of a
role of PCBs in the development of non-Hodgkin Lymphoma (NHL)
(Zani et al., 2013). Freeman and Kohles (Freeman and Kohles, 2012)
suggested a causal relationship between NHL and PCB exposure based
on the Bradford-Hill criteria. Kramer and colleagues (Kramer et al.,
2012), in their analyses of the scientific literature, concluded that the
weight of evidence was supportive of a causal role of PCBs in NHL; a bi-
ologically plausible explanation of this relationship is the immunosup-
pressive and inflammatory effects of PCBs.
A prospective cohort studywith 107 cases reported a dose–response
relationship between quartiles of increasing TL and risk of NHL (OR =
3.6; 95% CI: 1.4–8.9) (Lan et al., 2009). This association suggested that
individuals with longer telomeres have an elevated NHL risk.
One may expect that “from a biologic perspective, longer telomere
length should allow for longer cellular survival, the accumulation of ge-
netic mutations, and the possibility of accumulating potentially cancer
promoting mutations”; (Noy, 2009) therefore, our findings of the asso-
ciation of PCBs with longer LTL may suggest a plausible mechanistic
1978 F. Scinicariello, M.C. Buser / EBioMedicine 2 (2015) 1974–1979explanation for PCBs role inNHL development. PCBsmay act to preserve
LTL and possibly act as tumor promoters.
Studies in mice and rats demonstrated that PCBs are efficient tumor
promoters when administered for extended periods of time following
an initiating agent (Faroon et al., 2001; Safe, 1994). Several experimen-
tal systems associated activation of the proto-oncogene c-mycwith cel-
lular growth and proliferation programs (Dang, 2013) and thus an
important feature of cancer initiation and maintenance (Gabay et al.,
2014). Moreover, expression of TERT and telomerase activity is induced
by c-myc; (Greenberg et al., 1999) therefore, itmay be biologically plau-
sible that PCBs may contribute to telomere length maintenance or less-
ening the loss by attrition by inducing c-myc expression. Gribaldo and
colleagues (Gribaldo et al., 1998) showed that PCB138-exposed mouse
fibroblast T3-L1 cell lines cultured in serum-free media overexpressed
oncogenes that are involved in cell-cycle progression and proliferation,
among them c-myc. Exposure of 3T3-L1 cells with PCB169 or PCB126
showed increased expression of c-myc in media containing serum
(Gribaldo et al., 1998). Ghosh and colleagues (Ghosh et al., 2007) in an
in vitro experiment using human liver (HepG2) cells, showed that
chronic exposure of these cells with PCB153 overexpressed c-myc pro-
tein compared to short-term exposure. Another underlyingmechanism
for PCBs contribution to telomere length maintenance may be through
activation of the NF-κB which upregulate the human telomerase
(Akiyama et al., 2002; Zuo et al., 2011). Kwon and colleagues (Kwon
et al., 2002) reported induction of NF-κB of human leukemic mast cell
(HLMC) line exposed to PCB153.
There are few in vitro studies that investigate telomere length with
PCBs exposure. Immortalized human skin keratinocytes (HaCats) treat-
edwith non-dioxin-like PCB28 and PCB52 for up to 48days demonstrat-
ed a significant shortening of mean telomere length from days 18–48
(Senthilkumar et al., 2011). In another in vitro study, HaCat cells and
normal human foreskin keratinocytes (NFK) were treated with
PCB153 for up to 48 and 24 days, respectively (Senthilkumar et al.,
2012). Shortening of telomere length was found only in HaCat cells,
but not in NFK cells (Senthilkumar et al., 2012). These results may sug-
gest that PCB action on telomere length could be cell type specific. There
are no studies on telomerase activity induced by HPCDF or HXCDD.
However, in a study using human choriocarcinomaBeWo cell line expo-
sure to TCDD induced human telomerase both by direct and indirect in-
duction of c-myc (Sarkar et al., 2006). Therefore, it may be feasible that
also HPCDF and HXCDD may act in a similar fashion.
Although the strength of our study is that it is based on a nationally
representative survey, themain study limitation is the cross-sectional de-
sign of NHANES; therefore,we cannot infer a temporal, causal association.
There could also be confounding by other unmeasured variables, such as
dietary components (Tiainen et al., 2012), proportion of different leuko-
cyte subtypes (Lin et al., 2010). Furthermore, this study focused on the as-
sociation between POPs and LTL, but people are exposed to a wide-range
of chemicals including heavy metals and other pesticides that may have
had a confounding effect on the associations we observed.
In conclusion, in this largest study to date of exposure to POPs and
telomere length,we found an age-independent association between en-
vironmental exposures to PCBs,1,2,3,4,6,7,8-heptachlorodibenzofuran
and 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin and with LTL after adjust-
ment for potential confounders. Further studies, such as well-designed
prospective studies to evaluate the effect of PCBs on LTL, particularly
with morbidity outcomes, are needed to more fully understand the im-
plications of the findings of this study.
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